At Its Launch, STAR Trial Inherits Baggage Of Its Predecessor, P-1 Tamoxifin Study
In Brief: Strohl Leads Oncology Nursing Society; ONS Seeks Nominees For Consumer Panel
STAR Begins: Critics of Trial Call For Including A Placebo Arm
In The States: Illinois, Virginia approve Legislation Mandating Coverage of Care In Cancer Clinical Trials
Maryland to Use $1B In Tobacco Funds For Cancer Research, Anti-Smoking Program
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
- What happened at FDA? Replimune approval raises questions
- I grew up unhoused. Now, with support from ACS, I am an MD-PhD student focused on oncology
My mother instilled in me: “Never become a product of your circumstances.” - Duke Officials Silenced Med Student Who Reported Trouble in Anil Potti’s Lab
- FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial









